In this issue of Kidney International, the Dialysis Outcomes and Practice Patterns Study reports that hemodialysis patients with monthly intravenous iron supplementation of 300399?mg or greater than or equal to400?mg had a 13 or 18% higher risk of dying, respectively, compared with those receiving 100199?mg per month, with no obvious differences in cause-specific mortalities. This study supports that randomized controlled trials are urgently needed to identify optimized iron supplementation strategies for anemic dialysis patients.
Authors: G?nter Weiss and Florian Kronenberg
Reference: Kidney International (2015) 87, 1012; doi:10.1038/ki.2014.324
Additional Info
-
Language:
English -
Contains Audio:
No -
Content Type:
Articles -
Source:
KI -
Year:
2015 -
Members Only:
No